|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED
Nominal 
38.660 +3.980 (+11.476%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 1,706,678 | 141.507% | 706,678 | 125,932 | 12,792 | 54 |
| Cost of Sales | (524,775) | 191.876% | (179,794) | (34,414) | (4,645) | (23) |
| Gross Profit | 1,181,903 | 124.319% | 526,884 | 91,518 | 8,147 | 31 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 12,728 | 381.210% | 2,645 | 3,667 | (23,362) | (6,452) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (39,151) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (598,364) | -42.541% | (1,041,375) | (844,463) | (247,275) | (1,008,719) | |
| Taxation | 300,598 | -- | 0 | 0 | (8) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (297,766) | -71.406% | (1,041,375) | (844,463) | (247,283) | (1,008,719) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (42,014) | -42.465% | (73,024) | (84,608) | (32,887) | (24,065) |
| Depreciation & Amortisation | 156,524 | 17.143% | 133,618 | 76,966 | 42,772 | 31,124 |
| Directors' Emoluments | 80,764 | 11.346% | 72,534 | 42,398 | 68,728 | 106,387 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -89.000 | -72.531% | -324.000 | -270.000 | -83.000 | -344.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.275) | -- | (2.117) | (2.457) | (3.883) | (2.489) |
| NBV per share ($) | 15.000 | -- | 12.474 | 15.349 | 18.118 | 19.737 |
| Remarks: | Real time quote last updated: 27/03/2026 10:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -297,766 |
| %Change | -71.406% |
| EPS / (LPS) | RMB -0.890 |
| NBV Per Share (¥) | RMB 15.000 |